UPDATE : Thursday, April 9, 2020
상단여백
No Korean firms have entered trials to test COVID-19 drug candidates by Jeong Sae-im 2020-04-08 16:15
Samsung Biologics signs CDO contract with PharmAbcine by Shim Hyun-tai 2020-04-06 18:00
AbClon draws many new human antibodies to fight COVID-19 by Shim Hyun-tai 2020-03-30 17:47
ImmuneMed under fire for inflating drug’s effect against COVID-19 by Jeong Sae-im 2020-03-27 11:49
Warrant sought to arrest Medytox CEO for illegally making, selling Meditoxin by Jeong Sae-im 2020-03-25 14:09
라인
Will next-generation COVID-19 tests replace standard PCR checks? by Jeong Sae-im 2020-03-25 11:40
KoBioLabs' allergic immune disease treatment enters global clinical trial by Shim Hyun-tai 2020-03-23 16:03
CancerRop takes breather by dispelling listing concerns by Jeong Sae-im 2020-03-23 16:02
Samsung Bioepis’ biosimilar breast cancer treatment scores FDA’s nod by Lee Han-soo 2020-03-20 16:52
Samsung Biologics makes CDO partnership with Taiwanese bio-venture by Lee Han-soo 2020-03-17 17:31
라인
Celltrion Healthcare launches anticancer biosimilar Herzuma in US by Lee Han-soo 2020-03-17 16:21
‘Celltrion to invest ₩20 billion to develop COVID-19 cure in 6 months’ by Lee Han-soo 2020-03-13 17:38
SK Bioscience threatens MSD's sway over shingles vaccine market by Lee Han-soo 2020-03-12 17:05
Bridge Biotherapeutics, Atomwise to develop new drugs using AI by Lee Han-soo 2020-03-10 12:26
Celltrion applies for approval of new Humira biosimilar to EMA by Shim Hyun-tai 2020-03-09 16:40
라인
Celltrion Healthcare’s 2019 sales top ₩1 trillion by Lee Han-soo 2020-03-06 17:31
Samsung BioLogics, STCube to develop immunotherapies by Lee Han-soo 2020-03-03 16:18
Celltrion Healthcare presents Remsima SC in UK by Lee Han-soo 2020-03-02 17:42
HLB seeks new pipelines by taking over US biotech firm by Jeong Sae-im 2020-02-21 15:42
Celltrion’s annual revenue surpassed ₩1 trillion in 2019 by Jeong Sae-im 2020-02-20 15:47
여백
여백
여백
여백
Back to Top